J

Janchor Industrialist Investing | 建峖實業投資

36 employees

Janchor Partners is a long‐term industrialist investor, partnering with companies that have superior business models.

Investor insights

Sectors invested in

Pharmaceutical3
Health Care3
Biotechnology2
Medical2
商保PBM1
新药研发1
生物医药1
临床项目1
Biopharma1
Financial Services1
Finance1
Credit Cards1
FinTech1
Internet1
药品福利1
创新支付1

Funding rounds participated in

$228M sweet spot round size

Most of their 5 investments are in rounds between $75M and $308M

Investor type

Private Equity Firm

Basic info

Industry

investment management

Sectors

Finance

Date founded

2009

Investments made

F

FPL Technologies raised $75M on December 30, 2021

Investors: Matrix Partners, GIC, QED Investors, Hummingbird Ventures and Janchor Industrialist Investing | 建峖實業投資

镁

镁信健康 raised $308M on August 18, 2021

Investors: Lilly Asia Ventures, Lake Bleu Capital (Hong Kong) Limited, 中金公司, Boyu Capital, Marathon Venture Partners, New Alliance Capital and Janchor Industrialist Investing | 建峖實業投資

益

益方生物 InventisBio raised $147M on September 27, 2020

Investors: 厦门德屹股权投资管理有限公司, Lilly Asia Ventures, 经纬创投（北京）投资管理顾问有限公司, Qiming Venture Partners, OrbiMed Advisors, CMB International, E Fund Management Co.,LTD. and Janchor Industrialist Investing | 建峖實業投資

E

Everest Medicines raised $310M on June 3, 2020

Investors: Octagon Capital Advisors, Decheng Capital, Hillhouse Capital Management, RA Capital Management, L.P. and Janchor Industrialist Investing | 建峖實業投資

R

Rongchang Pharmaceutical Co., Ltd. raised undisclosed on March 16, 2020

Investors: Lake Bleu Capital (Hong Kong) Limited, Lilly Asia Ventures, OrbiMed Advisors, Vivo Capital, Hudson Bay Capital Management LP and Janchor Industrialist Investing | 建峖實業投資

FAQ